Skip to main content
Year archive

Kolon TissueGene, Inc. — 2023 filings

All 22 regulatory filings released by Kolon TissueGene, Inc. (950160) in 2023, sourced directly from the official regulator.

22 Filings
2023 Period
2023 filings (22)
Filing Released Lang
투자판단관련주요경영사항(임상시험계획승인신청등결정)(TG-C의 척추질환 적응증에 대한 FDA 제1상 임상시험계획신청(IND) 승인)
Legal Proceedings Report
2023-12-18 Korean
기타경영사항(자율공시)(제25기 정기주주총회 권리주주 확정을 위한 증권예탁증권(KDR) 기준일 설정 공고)
AGM Information
2023-12-13 Korean
투자판단관련주요경영사항(임상시험계획승인신청)(TG-C의 척추질환 적응증에 대한 FDA 제1상 임상시험계획승인신청(IND))
Regulatory Filings
2023-11-16 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-14 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-06-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-05-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-05-15 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-15 Korean
증권발행결과(자율공시)(제3자배정 유상증자)
Share Issue/Capital Change
2023-05-10 Korean
전환가액의조정
Capital/Financing Update
2023-05-10 Korean
[첨부추가]주요사항보고서(유상증자결정)
Share Issue/Capital Change
2023-04-27 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-03-31 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-28 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-28 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-20 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-20 Korean
주주총회소집결의
AGM Information
2023-03-13 Korean
주식매수선택권부여에관한신고
Share Issue/Capital Change
2023-03-13 Korean
주주총회소집공고
AGM Information
2023-03-13 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release FY 2022
2023-02-10 Korean